Untreated Adult Acute Myeloid Leukemia Completed Phase 3 Trials for Cytarabine (DB00987)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01802333Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid LeukemiaTreatment
NCT00003190Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid LeukemiaTreatment
NCT00003934Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic LeukemiaTreatment
NCT00006363Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaTreatment
NCT00085124Daunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid LeukemiaTreatment